QQ客服 官方微博 反馈留言

	Beside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targets
	Chen, Shuhui; Cavazza, Elisa; Barlier, Catherine; Salleron, Julia; Filhine-Tresarrieu, Pierre; Gavoilles, Celine; Merlin, Jean-Louis; Harle, Alexandre
刊名	ONCOLOGY LETTERS
	2016
卷号	12期号:5
关键词	high-grade serous ovarian carcinoma signaling pathway high resolution melting-polymerase chain reaction immunohistochemistry targeted therapy next generation sequencing
ISSN号	1792-1074
DOI	10.3892/ol.2016.5083
URL标识	查看原文
收录类别	SCIE
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4049264
专题	武汉大学
推荐引用方式 GB/T 7714	Chen, Shuhui,Cavazza, Elisa,Barlier, Catherine,et al. Beside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targets[J]. ONCOLOGY LETTERS,2016,12(5).
APA	Chen, Shuhui.,Cavazza, Elisa.,Barlier, Catherine.,Salleron, Julia.,Filhine-Tresarrieu, Pierre.,...&Harle, Alexandre.(2016).Beside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targets.ONCOLOGY LETTERS,12(5).
MLA	Chen, Shuhui,et al."Beside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targets".ONCOLOGY LETTERS 12.5(2016).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。